Supporting Cannabinoid Research from Discovery to Early Phase Clinical Trials.

What We Do.

  • Get cannabinoid research projects funded through NIH.

  • Make GLP/GMP grade cannabinoids.

  • Support projects into clinical trials.

How We Do It.

  • No-cost grant writing to expedite NIH R01 grant submissions.

  • Research grade and GCP/GMP grade cannabinoid molecules.

  • Intellectual Property protection and partnering toward pharmaceutical drug development.

Our Team

  • Debra Kimless, MD

    Principal Investigator, and Board Member of the International Alliance for Cannabinoid Medicines.

  • Stephen J. Goldner, Esq

    The co-inventor of liquid Methadone who has shepherded over 240 medical devices and drugs to FDA approval.

  • Justin Serianni, Esq

    Former General Counsel to a publicly traded cannabis company with deep experience in regulatory, compliance, and risk management programs.

  • Athan Koutsiouroumbas

    Public finance and regulatory professional with expertise in securing Federal and State support for innovative projects.

Work With Us.

  • Launching in 2024, we seek Principal Investigators to take cannabinoids from Discovery to Early Clinical Trial phases.